SPNC 32.79 The Spectranetics Corp $SPNC Hit a 52 week high of 32.98 Currently at 32.79 -0.26 -0.79% With a day low of 32.78 and a total volume of 7,000.
SPNC The Spectranetics Corp Recent Headline News
Insider Trading Alert - CCL, SYRG And SPNC Traded By Insiders
at The Street - Thu Nov 06, 9:30AM CST
Stocks with insider trader activity include CCL, SYRG and SPNC
SPNC: 32.72 (-0.33), CCL: 40.27 (-0.13), SYRG: 11.97 (-0.29)
Spectranetics to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Nov 05, 3:01PM CST
The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in three upcoming investor conferences.
SPNC: 32.72 (-0.33)
Can The Spectranetics (SPNC) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:41AM CST
The Spectranetics could be a great candidate for another beat after a solid performance in the last two quarters.
SPNC: 32.72 (-0.33)
Spectranetics to buy Stellarex drug coated balloon assets to treat complex vascular conditions in projected USD700m drug coated balloon segment
M2 - Mon Nov 03, 6:21AM CST
The Spectranetics (NasdaqGS:SPNC) reported on Sunday the launch of a definitive agreement to acquire Covidien's (NYSE:COV) Stellarex drug coated angioplasty balloon (DCB) platform to treat peripheral arterial disease for USD30m.
SPNC: 32.72 (-0.33), MDT: 68.45 (+0.35), COV: 92.55 (+0.47)
Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien
GlobeNewswire - Sun Nov 02, 6:00PM CST
Conference Call Monday at 8:30 a.m. ET
SPNC: 32.72 (-0.33), COV: 92.55 (+0.47)
The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:21AM CDT
The Spectranetics Corporation (SPNC) was a big mover last session, as the company saw its shares soar by over 13% on the day.
SPNC: 32.72 (-0.33), VRX: 127.76 (+1.65), PSTI: 2.66 (unch), MYL: 53.84 (+0.73)
Nasdaq stocks posting largest percentage increases
AP - Fri Oct 24, 5:35PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
DRIV: 24.76 (+0.08), SPNC: 32.72 (-0.33), STRT: 105.05 (+0.09), MMSI: 15.03 (+0.09)
Spectranetics beats Street 3Q forecasts
Automated Insights - Thu Oct 23, 6:10PM CDT
COLORADO SPRINGS, Colo. (AP) _ The Spectranetics Corp. (SPNC) on Thursday reported a loss of $13.9 million in its third quarter.
SPNC: 32.72 (-0.33)
Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million
GlobeNewswire - Thu Oct 23, 3:02PM CDT
FDA Clearance of In-Stent Restenosis Indication Achieved;
SPNC: 32.72 (-0.33)
BMTC, SSD, MCBC, SPNC, CNMD, HBHC Expected To Be Down After Next Earnings Releases
M2 - Thu Oct 23, 3:34AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 23rd 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and October earnings reports. Bryn Mawr Bank Corp (NASDAQ:BMTC), Simpson Manufacturing Co Inc (NYSE:SSD), Macatawa Bank Corp (NASDAQ:MCBC), Spectranetics Corp (NASDAQ:SPNC), CONMED CORPORATION (NASDAQ:CNMD), Hancock Holding Co (NASDAQ:HBHC) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
SPNC: 32.72 (-0.33), CNMD: 41.93 (+0.16), HBHC: 35.03 (+0.19), MCBC: 5.24 (-0.02), SSD: 33.18 (-0.28), BMTC: 30.63 (-0.01)
Spectranetics to Hold 2014 Third Quarter Financial Results Conference Call on October 23
GlobeNewswire - Thu Oct 09, 3:01PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2014 third quarter financial results after market close on Thursday, October 23, 2014. Company management will host an investment-community conference call beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on Thursday, October 23 to discuss those results and to answer questions.
SPNC: 32.72 (-0.33)
Shares of SPNC Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 06, 9:36AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 12.54% as of today's recent price of $27.05.
SPNC: 32.72 (-0.33)
Uptrend Call Working As Spectranetics Stock Rises 12.2% (SPNC)
Comtex SmarTrend(R) - Fri Sep 26, 9:54AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 12.19% as of today's recent price of $26.97.
SPNC: 32.72 (-0.33)
Spectranetics Has Returned 16.8% Since SmarTrend Recommendation (SPNC)
Comtex SmarTrend(R) - Fri Sep 19, 9:18AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 16.83% as of today's recent price of $28.08.
SPNC: 32.72 (-0.33)
Insider Trading Alert - HNT, SPNC And MEAS Traded By Insiders
at The Street - Thu Sep 18, 9:15AM CDT
Stocks with insider trader activity include HNT, SPNC and MEAS
SPNC: 32.72 (-0.33), MEAS: 86.00 (+0.01), HNT: 47.60 (+0.59)
EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at TCT 2014
GlobeNewswire - Tue Sep 16, 10:42AM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that Eric Dippel, MD, at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, presented findings from the EXCITE ISR clinical trial proving Spectranetics' laser atherectomy devices, used with PTA (also known as balloon angioplasty), are clinically superior to PTA alone in both safety and efficacy, triggering a new standard in cardiovascular care.
SPNC: 32.72 (-0.33)
Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.
GlobeNewswire - Wed Sep 10, 8:29AM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that data from EXCITE ISR will be presented as a late-breaking clinical trial at the 26th Transcatheter Cardiovascular Therapeutics(TCT) conference taking place in Washington, D.C., September 13-17, 2014. Eric J. Dippel, MD, will present clinical findings on EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis. Spectranetics will also be hosting a symposium to review the findings - Novel Indication for Treatment of ISR: The Right Path is Clear.
SPNC: 32.72 (-0.33)
SPNC The Spectranetics Corp Recent Headline News
Insider Trading Alert - CCL, SYRG And SPNC Traded By Insiders
at The Street - Thu Nov 06, 9:30AM CST
Stocks with insider trader activity include CCL, SYRG and SPNC
SPNC: 32.72 (-0.33), CCL: 40.27 (-0.13), SYRG: 11.97 (-0.29)
Spectranetics to Participate in Upcoming Investor Conferences
GlobeNewswire - Wed Nov 05, 3:01PM CST
The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in three upcoming investor conferences.
SPNC: 32.72 (-0.33)
Can The Spectranetics (SPNC) Keep the Earnings Streak Alive This Quarter? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:41AM CST
The Spectranetics could be a great candidate for another beat after a solid performance in the last two quarters.
SPNC: 32.72 (-0.33)
Spectranetics to buy Stellarex drug coated balloon assets to treat complex vascular conditions in projected USD700m drug coated balloon segment
M2 - Mon Nov 03, 6:21AM CST
The Spectranetics (NasdaqGS:SPNC) reported on Sunday the launch of a definitive agreement to acquire Covidien's (NYSE:COV) Stellarex drug coated angioplasty balloon (DCB) platform to treat peripheral arterial disease for USD30m.
SPNC: 32.72 (-0.33), MDT: 68.45 (+0.35), COV: 92.55 (+0.47)
Spectranetics to Acquire Stellarex(TM) Drug Coated Balloon Assets From Covidien
GlobeNewswire - Sun Nov 02, 6:00PM CST
Conference Call Monday at 8:30 a.m. ET
SPNC: 32.72 (-0.33), COV: 92.55 (+0.47)
The Spectranetics Corporation (SPNC) in Focus: Stock Soars 13.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:21AM CDT
The Spectranetics Corporation (SPNC) was a big mover last session, as the company saw its shares soar by over 13% on the day.
SPNC: 32.72 (-0.33), VRX: 127.76 (+1.65), PSTI: 2.66 (unch), MYL: 53.84 (+0.73)
Nasdaq stocks posting largest percentage increases
AP - Fri Oct 24, 5:35PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
DRIV: 24.76 (+0.08), SPNC: 32.72 (-0.33), STRT: 105.05 (+0.09), MMSI: 15.03 (+0.09)
Spectranetics beats Street 3Q forecasts
Automated Insights - Thu Oct 23, 6:10PM CDT
COLORADO SPRINGS, Colo. (AP) _ The Spectranetics Corp. (SPNC) on Thursday reported a loss of $13.9 million in its third quarter.
SPNC: 32.72 (-0.33)
Spectranetics Achieves Third Quarter 2014 Revenue of $58.8 Million
GlobeNewswire - Thu Oct 23, 3:02PM CDT
FDA Clearance of In-Stent Restenosis Indication Achieved;
SPNC: 32.72 (-0.33)
BMTC, SSD, MCBC, SPNC, CNMD, HBHC Expected To Be Down After Next Earnings Releases
M2 - Thu Oct 23, 3:34AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Thursday, October 23rd 2014 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and October earnings reports. Bryn Mawr Bank Corp (NASDAQ:BMTC), Simpson Manufacturing Co Inc (NYSE:SSD), Macatawa Bank Corp (NASDAQ:MCBC), Spectranetics Corp (NASDAQ:SPNC), CONMED CORPORATION (NASDAQ:CNMD), Hancock Holding Co (NASDAQ:HBHC) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go Down After earnings are released Thursday:
SPNC: 32.72 (-0.33), CNMD: 41.93 (+0.16), HBHC: 35.03 (+0.19), MCBC: 5.24 (-0.02), SSD: 33.18 (-0.28), BMTC: 30.63 (-0.01)
Spectranetics to Hold 2014 Third Quarter Financial Results Conference Call on October 23
GlobeNewswire - Thu Oct 09, 3:01PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2014 third quarter financial results after market close on Thursday, October 23, 2014. Company management will host an investment-community conference call beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on Thursday, October 23 to discuss those results and to answer questions.
SPNC: 32.72 (-0.33)
Shares of SPNC Up 12.5% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Mon Oct 06, 9:36AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 12.54% as of today's recent price of $27.05.
SPNC: 32.72 (-0.33)
Uptrend Call Working As Spectranetics Stock Rises 12.2% (SPNC)
Comtex SmarTrend(R) - Fri Sep 26, 9:54AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 12.19% as of today's recent price of $26.97.
SPNC: 32.72 (-0.33)
Spectranetics Has Returned 16.8% Since SmarTrend Recommendation (SPNC)
Comtex SmarTrend(R) - Fri Sep 19, 9:18AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on May 27th, 2014 at $24.04. In approximately 4 months, Spectranetics has returned 16.83% as of today's recent price of $28.08.
SPNC: 32.72 (-0.33)
Insider Trading Alert - HNT, SPNC And MEAS Traded By Insiders
at The Street - Thu Sep 18, 9:15AM CDT
Stocks with insider trader activity include HNT, SPNC and MEAS
SPNC: 32.72 (-0.33), MEAS: 86.00 (+0.01), HNT: 47.60 (+0.59)
EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at TCT 2014
GlobeNewswire - Tue Sep 16, 10:42AM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that Eric Dippel, MD, at Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, presented findings from the EXCITE ISR clinical trial proving Spectranetics' laser atherectomy devices, used with PTA (also known as balloon angioplasty), are clinically superior to PTA alone in both safety and efficacy, triggering a new standard in cardiovascular care.
SPNC: 32.72 (-0.33)
Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.
GlobeNewswire - Wed Sep 10, 8:29AM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that data from EXCITE ISR will be presented as a late-breaking clinical trial at the 26th Transcatheter Cardiovascular Therapeutics(TCT) conference taking place in Washington, D.C., September 13-17, 2014. Eric J. Dippel, MD, will present clinical findings on EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis. Spectranetics will also be hosting a symposium to review the findings - Novel Indication for Treatment of ISR: The Right Path is Clear.
SPNC: 32.72 (-0.33)
